Molecular Neurobiology

Special Issues

Following special issues within this section are currently open for submissions:

• Understanding the Impacts of Neurodevelopmental Cannabinoid Exposure (Deadline: 31 May 2022)
• Stress-Related Disorders and Depression: From Molecular Basis to Therapy (Deadline: 31 May 2022)
• The Neurobiology of Substance Addiction (Deadline: 31 May 2022)
• Molecular Mechanisms of Neuropathic Pain and Nerve Injury (Deadline: 31 May 2022)
• Advance in Research on Neurogenesis (Deadline: 31 May 2022)
• Molecular Mechanisms and Pathophysiology of Cerebral Ischemia (Deadline: 31 May 2022)
• Molecular Mechanisms, Pathophysiology and Phenotypes of Mitochondrial Disorders (Deadline: 31 May 2022)
• Neurobiology of Aging and Aging-Related Disorders (Deadline: 31 May 2022)
• The Molecular Brain and Its Health (Deadline: 31 May 2022)
• Role of Astrocytes in Neurological Diseases (Deadline: 31 May 2022)
• Neuro–Immune Interactions in Health and Disease (Deadline: 31 May 2022)
• Connecting In Vitro, In Vivo, and Ex Vivo Studies in Neurodegenerative Diseases (Deadline: 31 May 2022)
• Role of Extracellular Matrix Molecules in CNS Injury, Aging and Neurodegenerative Disease (Deadline: 31 May 2022)
• Development of New Drugs against Stroke (Deadline: 31 May 2022)
• Neurodegenerative Diseases: From Molecular Basis to Therapy (Deadline: 31 May 2022)
• Towards an Understanding of Retinal Diseases and Novel Treatment 2.0 (Deadline: 31 May 2022)
• Disease Modifying Translational Research for Neurological Disorders and Brain Damages (Deadline: 31 May 2022)
• Neurofibromatosis: Study of Molecular Mechanisms (Deadline: 31 May 2022)
• Frontiers in Glioma Pathobiology (Deadline: 31 May 2022)
• Neuroendocrine Factors in Health and Disease (Deadline: 31 May 2022)
• Neurolipids in Neurodegenerative Disorders (Deadline: 31 May 2022)
• Biological Functions of Neurotrophins: New Insights from Canonical and Noncanonical Model Organisms (Deadline: 31 May 2022)
• Frontiers in Molecular Mechanisms of Stroke (Deadline: 31 May 2022)
• Neurogenesis and Neural Plasticity 2.0 (Deadline: 31 May 2022)
• Neurotoxins in the Neurosciences: Molecular Mechanisms and Applications 2.0 (Deadline: 31 May 2022)
• Glioma: Molecular Aspects and Theranostics (Deadline: 31 May 2022)
• Brain/Mind Activity and Molecular Dynamics in Biological Systems (Deadline: 15 June 2022)
• Alzheimer's disease: From Molecular Basis to Therapy (Deadline: 15 June 2022)
• Retinal Degeneration and Protection (Deadline: 24 June 2022)
• Astrocyte–Neuron Communication in Neurological Disorders (Deadline: 25 June 2022)
• Synaptic Plasticity and Diseases (Deadline: 30 June 2022)
• Sodium Voltage-Operated Neural Channel Modulators in Peripheral Nervous System Disorders (Deadline: 30 June 2022)
• Cellular and Molecular Mechanisms in Neurodevelopmental Disorders and Brain Tumors (Deadline: 30 June 2022)
• State-of-the-Art Molecular Neurobiology in Chile (Deadline: 30 June 2022)
• New Advances in Research on Alzheimer's Disease (Deadline: 30 June 2022)
• Peripheral Biomarkers in Neurodegenerative Diseases 3.0 (Deadline: 30 June 2022)
• Molecular Mechanisms of Aging-Related Neurodegenerative Diseases (Deadline: 30 June 2022)
• Newly Developed Drugs for Alzheimer's Disease (Deadline: 30 June 2022)
• Advances in the Research of Neural Circuits (Deadline: 30 June 2022)
• The Pathogenesis and Therapeutic Strategies for Understanding and Treating Diabetic Neuropathy of the Retina (Deadline: 30 June 2022)

• Non-Coding RNAs in Human Neurodevelopmental Disorders and Brain Disorders

  (Deadline: 30 June 2022)
• Brain Neurotransmitters in Genetic Control of Behavior 2.0 (Deadline: 30 June 2022)
• Inflammation in Neurodegeneration (Deadline: 30 June 2022)
• Disorders of Cholesterol Homeostasis (Deadline: 30 June 2022)
• Alterations of Cell-to-Cell Communication in the Aging Brain and in Neurological Diseases (Deadline: 30 June 2022)
• Lipids in Neurodegenerative Disorders (Deadline: 30 June 2022)
• Recent Advances on Mitochondrial Diseases (Deadline: 30 June 2022)
• Exosome: New Approaches of Therapy for Neurodegenerative Diseases (Deadline: 30 June 2022)
• Advances in Neurodevelopmental Disorders (NDDs) Research (Deadline: 30 June 2022)
• Cerebellar Ataxia (Deadline: 30 June 2022)
• Synaptic Vulnerability: From Biological to Therapeutic Point of View (Deadline: 30 June 2022)
• Advances in Stress and Depression Research: Neurobiology, Models, Biomarkers and Therapies (Deadline: 30 June 2022)
• Proteinopathies in Frontotemporal Lobar Degeneration (Deadline: 30 June 2022)
• Advances in Neurodegenerative Diseases Research and Therapy (Deadline: 30 June 2022)
• Molecular Mechanisms of Neural Circuit Development and Regeneration 2.0 (Deadline: 30 June 2022)
• Development of Dopaminergic Neurons (Deadline: 30 June 2022)
• Neuroinflammation in Parkinson's Disease (Deadline: 30 June 2022)
• Cellular Mechanisms in Neuropathic Pain (Deadline: 30 June 2022)
• Epigenetic Age Acceleration in Neurodevelopmental and Cognitive Disorders (Deadline: 30 June 2022)
• Molecular Mechanisms of Neuronal Death in Neurodegeneration (Deadline: 30 June 2022)
• Neuropathology and Cellular Mechanisms in Traumatic Brain Injury (Deadline: 30 July 2022)
• Neuroinflammation: From Molecular Mechanisms to Therapeutic Perspectives (Deadline: 30 July 2022)
• Molecular Advances in Schizophrenia (Deadline: 31 July 2022)
• Molecular Mechanisms of Addictive Disorders (Deadline: 31 July 2022)
• Mitochondrial Dynamics in Neurons (Deadline: 31 July 2022)
• Endovascular Treatment and Interventional Neurology (Deadline: 31 July 2022)
• New Molecular Insights into Neurocutaneous Syndromes (Deadline: 31 July 2022)
• Effect of Mesenchymal Stem Cells on Neurogenesis, Affective and Cognitive Behavior (Deadline: 31 July 2022)
• Frontier on Alzheimer's Disease (Deadline: 31 July 2022)
• Molecular and Cellular Mechanisms of Synchronization within the Mammalian Circadian System (Deadline: 31 July 2022)
• Molecular Research on Mental Disorders (Deadline: 31 July 2022)
• Spine and Spinal Cord Injury (Deadline: 31 July 2022)
• Modulation of Neuronal Excitability, Synaptic Transmission, and Plasticity in Health and Disease 2.0 (Deadline: 31 July 2022)
• Molecular Research on Amyotrophic Lateral Sclerosis (Deadline: 31 July 2022)
• The Role of Neurons in Human Health and Disease (Deadline: 31 July 2022)
• The Mechanisms Regulation of the Neuromuscular Dysfunctions (Deadline: 31 July 2022)
• Molecules Affecting Brain Development and Nervous System (Deadline: 31 July 2022)
• Regulation and Function of Neural Attributes: From Gene to Behavior (Deadline: 31 July 2022)
• The Role of Neuroimmune Inflammation in Chemotherapy-Induced Side Effects (Deadline: 31 July 2022)
• Drosophila Models for Neurodegenerative Diseases: Achievements and Prospects (Deadline: 31 July 2022)
• Neuronal Voltage-Gated Channel Regulation (Deadline: 15 August 2022)
• Responsible Factors for Neuromorphogenesis in the Brain (Deadline: 31 August 2022)
• Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases (Deadline: 31 August 2022)
• Molecular Research on Neural Stem Cells in Physiological and Pathological Condition (Deadline: 31 August 2022)
• Genetic and Molecular Regulations of Neuronal Activity (Deadline: 31 August 2022)
• Kinase-Mediated Signaling in Mood Disorders (Deadline: 31 August 2022)
• Modeling Neurological Disorders in Experimental Animals: New Insights and Emerging Roles 2.0 (Deadline: 31 August 2022)
• Neural Dynamics and Regulation in Epilepsy (Deadline: 31 August 2022)
• Molecular Research on Rett Syndrome and Related Disorders 2.0 (Deadline: 31 August 2022)
• Gut-Brain Axis of Neurodegenerative Disease (Deadline: 31 August 2022)
• Molecular Research on Parkinson's Disease (Deadline: 31 August 2022)
• Roles of Glia in CNS: Toward the Development of New Antidepressant Strategies? (Deadline: 31 August 2022)
• Neurobiology of Vision in Health and Disease (Deadline: 31 August 2022)
• Immunology of Neuropsychiatric Disorders (Deadline: 31 August 2022)
• Oligodendrocytes and Neurovascular Unit (Deadline: 31 August 2022)
• Research of Neuronal Cell in Nervous System Development and Disease (Deadline: 31 August 2022)
• Autophagy in the Nervous System (Deadline: 31 August 2022)
• Glycome and Nervous System (Deadline: 31 August 2022)
• Advances in the Research of Acute Ischemic Stroke (Deadline: 31 August 2022)
• The Gut–Liver–Brain Axis: From Head to Feet (Deadline: 31 August 2022)
• Neuroinflammation: From Molecular Basis to Therapy (Deadline: 31 August 2022)
• Cell Signaling in Neurodegeneration 3.0 (Deadline: 31 August 2022)
• Intersection between Cognitive Impairment and Metabolic Alterations in the Molecular Mechanisms of Neurodegeneration (Deadline: 31 August 2022)
• Advances in Epilepsy and Headache (Deadline: 31 August 2022)
• Novel Therapeutic Approaches for Neural Repair (Deadline: 31 August 2022)
• Impact of Lipid Homeostasis in Neurodegenerative Diseases (Deadline: 15 September 2022)
• Proteomics in Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 22 September 2022)
• Prions and Prion Diseases 3.0 (Deadline: 25 September 2022)
• Molecular Researches on Ischemic Stroke (Deadline: 30 September 2022)
• mTOR Signaling in Inflammation, Brain Injuries and Neurodegeneration (Deadline: 30 September 2022)
• Molecular Regulators and Investigation of Neurodegeneration Diseases (Deadline: 30 September 2022)
• Epigenetic Mechanisms of Neurodegenerative Diseases (Deadline: 30 September 2022)
• Plasticity and Neurodegenerative Diseases (Deadline: 30 September 2022)
• Gender-Related Molecular Mechanism in Neurological Disorders (Deadline: 30 September 2022)
• Synucleins in Neurodegeneration (Deadline: 30 September 2022)
• Latest Advances in Neuroscience (Deadline: 30 September 2022)
• Molecular Mechanism of Natural Compounds in Neuroinflammation (Deadline: 30 September 2022)
• Biochemical and Molecular Adaptation to Neuromuscular Conditioning (Deadline: 30 September 2022)
• Applications of Mesenchymal Stem Cells in Neuroscience 2.0 (Deadline: 30 September 2022)
• GABAergic and Glycinergic Neurons (Deadline: 30 September 2022)
• Neurobiology of Protein Synuclein (Deadline: 30 September 2022)
• The Link between Stem Cells and Nervous System (Deadline: 30 September 2022)
• Neuropathic Pain Molecular Mechanism and Therapy (Deadline: 30 September 2022)
• Sexual Dimorphism in Neurological Diseases: From Molecular Basis to Therapy (Deadline: 30 September 2022)
• Neural Correlates and Molecular Mechanisms of Memory and Learning (Deadline: 30 September 2022)
• Molecular Pharmacology and Genomics in Psychiatry (Deadline: 30 September 2022)
• TDP-43 Biology and Pathology (Deadline: 30 September 2022)
• Neuro-Oncology: From Molecular Basis to Therapy (Deadline: 12 October 2022)
• Physiological or Pathological Molecular Alterations in Brain Aging 2.0 (Deadline: 15 October 2022)
• Updates on Neuroendocrine Research in Health and Disease (Deadline: 15 October 2022)
• Molecular Biomarkers in Neurodevelopmental and Neurodegenerative Disorders (Deadline: 20 October 2022)
• Molecular Research on Neurodegenerative Diseases 3.0 (Deadline: 25 October 2022)
• CNS Drug Action in Neurodegenerative Diseases 2.0 (Deadline: 30 October 2022)
• Molecular and Cellular Research on Optic Nerve Disease (Deadline: 31 October 2022)
• Neurogenetics in Neurology (Deadline: 31 October 2022)
• Neurometabolic Disorders in the Adults (Deadline: 31 October 2022)
• Molecular Research in Neuroimmunological Disorders (Deadline: 31 October 2022)
• Molecular Insights in Psychiatry 2.0 (Deadline: 31 October 2022)
• Alpha-Synuclein in Neurological Disorders: From Physiology to Pathology (Deadline: 31 October 2022)
• Neurodegenerative Diseases and Intellectual Disabilities: From Molecular Basis to Therapy (Deadline: 31 October 2022)
• Recent Advances in the Research of Mental Disorders (Deadline: 31 October 2022)
• The Role of Natural Products in the Treatment of Neuronal Disease (Deadline: 31 October 2022)
• Autoimmunity in the Nervous Systems: Multiple Sclerosis and Beyond 2.0 (Deadline: 31 October 2022)
• Brain-Body Bidirectional Communication and Its Relevance for Cerebrovascular Diseases (Deadline: 31 October 2022)
• Metabolic Influences on Neurodegeneration (Deadline: 31 October 2022)
• Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules 2.0 (Deadline: 31 October 2022)
• Neural and Vascular Dysfunctions in Retinal Diseases: Mechanisms and Treatments (Deadline: 31 October 2022)
• Alzheimer’s Disease Pathogenesis, Diagnostics, and Treatment in The Early Stages (Deadline: 31 October 2022)
• Recent Advances on Meningiomas (Deadline: 31 October 2022)
• Pathogenesis and Treatment Mechanisms of Depression (Deadline: 31 October 2022)
• The Multiple Mechanisms Underlying Neuropathic Pain (II) (Deadline: 31 October 2022)
• Pathogenesis of Diseases of the Central Nervous System (Deadline: 31 October 2022)
• Molecular Mechanisms of Neural Stem Cells (NSC) Development - Systems Approach (Deadline: 31 October 2022)
• Zebrafish Models in Toxicology and Disease Studies (Deadline: 31 October 2022)
• Biomarkers in Common and Rare Neurological Disorders (Deadline: 31 October 2022)
• Molecular Mechanism Underlying Rare Inherited Neurological Diseases (Deadline: 31 October 2022)
• Molecular and Cellular Neurobiology of Migraine (Deadline: 10 November 2022)
• Role and Dynamics of Extracellular Vesicles in Central Nervous System Diseases 2.0 (Deadline: 15 November 2022)
• Role of Dopamine in Health and Disease—Biological Aspect (Deadline: 15 November 2022)
• Beyond the Primary Infarction: Focus on Mechanisms Related to Secondary Neurodegeneration after Stroke 2022 (Deadline: 15 November 2022)
• Molecular Biomarkers in Neurological Diseases (Deadline: 15 November 2022)
• Neurolipids in Neurodegenerative Processes (Deadline: 30 November 2022)
• Molecular Mechanisms of Schizophrenia and Novel Targets 2.0 (Deadline: 30 November 2022)
• Brain Mechanisms of Sleep Related Disorders 2.0 (Deadline: 30 November 2022)
• Protein Aggregates Toxicity: New Insights into the Mechanisms 2.0 (Deadline: 30 November 2022)
• Molecular Mechanisms and Pathophysiology of Neuronal Aging (Deadline: 30 November 2022)
• Ischemic Brain Neurodegeneration 2.0 (Deadline: 30 November 2022)
• Molecular Pathogenesis of Alzheimer's Disease 2.0 (Deadline: 30 November 2022)
• Novel Concepts, New Perspectives, and Current Therapies for Parkinson's Disease (Deadline: 30 November 2022)
• Molecular Mechanisms of Synaptic Plasticity 3.0 (Deadline: 30 November 2022)
• Identifying the Molecular Mechanisms of Psychiatric Disorders to Define New Therapeutic Targets (Deadline: 30 November 2022)
• The Role of Cerebrospinal Fluid and Blood Biomarkers in Neurological Diseases (Deadline: 30 November 2022)
• Plasticity of the Nervous System after Injury (Deadline: 10 December 2022)
• Early Diagnosis and Monitoring of Neuroendocrine Tumours: State of the Art and Future Perspectives (Deadline: 10 December 2022)
• New Breakthrough in Alzheimer’s Pathogenesis (Deadline: 10 December 2022)
• Recent Progress in Multiple Sclerosis 2.0 (Deadline: 10 December 2022)
• Genomics of Brain Disorders 4.0 (Deadline: 15 December 2022)
• Molecular Research in Neuro-Urology (Deadline: 20 December 2022)
• Amyotrophic Lateral Sclerosis as a Systemic Disease (Deadline: 30 December 2022)
• Neurobiology of Parkinson’s Disease (Deadline: 31 December 2022)
• Neuron and Brain Maturation 2.0 (Deadline: 31 December 2022)
• Molecular Mechanisms and Therapies in Neurological Diseases 2022 (Deadline: 31 December 2022)
• Mitochondria as a Cellular Hub in Neurological Disorders (Deadline: 31 December 2022)
• Epigenetic Regulation in Neurodegeneration Disease 2.0 (Deadline: 31 December 2022)
• Neuropathological Advances in Brain Disorders from MNS2022 (Deadline: 31 December 2022)
• New Trends in Alzheimer's Disease Research: From Molecular Mechanisms to Therapeutics (Deadline: 31 January 2023)
• Neuroprotective Effect of Glutathione 2.0 (Deadline: 31 May 2023)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Neurobiology
• Neuroimmunology
• Neuroinflammatory Processes in Neurodegenerative Diseases
• Neuroprotective Strategies
• State-of-the-Art Molecular Neurobiology in Germany
• State-of-the-Art Molecular Neurobiology in Italy
• State-of-the-Art Molecular Neurobiology in Japan
• State-of-the-Art Molecular Neurobiology in Korea
• State-of-the-Art Molecular Neurobiology in Poland
• State-of-the-Art Molecular Neurobiology in Russia
• State-of-the-Art Molecular Neurobiology in Spain
• State-of-the-Art Molecular Neurobiology in Switzerland
• State-of-the-Art Molecular Neurobiology in UK
• State-of-the-Art Molecular Neurobiology in USA